1. Genomic Testing Gap: Half of Metastatic Cancer Patients Miss Key Sequencing, Disparities Widen
A critical diagnostic step is being missed for a vast number of patients with advanced cancer, potentially locking them out of life-extending, targeted treatments. A new study reveals that for most metastatic cancers examined, only about half of patients ever receive genomic sequencing of their tumors—a foundational te...